Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, Estebán Martínez, José L Blanco et al.|The Lancet HIV|2025Cited by 22
Persistent Minor Blips of HIV Viral Load in Patients on ART Are Associated With Virological Failure and Higher Rates of Clinical Events.Enrique Bernal, CoRIS Study, Mar Masiá et al.|Research Square|2021Cited by 0